Wells Fargo’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Wells Fargo's RGEN Position: Q1 2026 in Review
Wells Fargo reduced its Repligen (RGEN) stake by 1.5% in Q1 2026, selling an estimated $78.8K and leaving 35,905 shares worth $4.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2733.
Wells Fargo first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $258M in Q3 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Wells Fargo held 35,905 shares of Repligen worth $4.23M as of Q1 2026.
- Wells Fargo sold 564 Repligen shares in Q1 2026, an estimated $78.8K.
- Repligen made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2733 holding.
- Wells Fargo first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Repligen position peaked at $258M in Q3 2021.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.